You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新安股份(600596.SH):擬出資8億元受讓穎泰生物12.31%股份
格隆匯 09-03 15:36

格隆匯9月3日丨新安股份(600596.SH)公佈,2021年6月9日,公司與華邦生命健康股份有限公司(華邦健康)、北京穎泰嘉和生物科技股份有限公司(穎泰生物)簽訂了《戰略合作協議》,各方在協議中約定:以穎泰生物作為合作平台,在農化、轉基因領域的產品佈局、產業鏈拓展、市場及渠道協同等方面建立全面、深入的戰略合作伙伴關係,以推動各方的業務共同發展。華邦健康將擇機採取包括但不限於向公司轉讓其合法持有的穎泰生物股權,或同意公司參與穎泰生物增資擴股等合法合規方式,支持公司成為穎泰生物重要股東。

2021年9月3日,公司與華邦健康簽訂《股份轉讓協議》,公司出資8.00億元,以每股5.30元受讓其持有的穎泰生物15095萬股股份,佔穎泰生物總股本的12.31%。受讓完成後,公司持有穎泰生物12.31%股份,成為其第二大股東。

公司此次受讓穎泰生物股份,有助於公司落實與穎泰生物的戰略合作,促進雙方在技術研發、生產基地、市場渠道、產業鏈管理等方面的協同,進一步優化產品和產業佈局,提升公司為行業提供植保綜合解決方案的能力,擴大公司農化業務規模,增強農化業務的核心競爭力與可持續發展能力,進一步夯實公司的行業領先地位,符合公司發展戰略。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account